Literature DB >> 34231114

Acute basilar artery occlusion (BAO): a pictorial review of multimodal imaging findings.

Andrés Yesid Vásquez-Codina1, Juan Martín Leguízamo-Isaza2, Nahala Fahed Aborashed-Amador3, Juan Carlos Aldana-Leal4, Carlos Hernán Roa-Mejía4.   

Abstract

Acute basilar artery occlusion (BAO) is an uncommon cause of stroke; however, it constitutes a serious medical emergency and is associated with elevated mortality rates as well as unfavorable functional outcomes. This is especially true when it is not rapidly diagnosed, and the initiation of reperfusion therapies is delayed. Its etiology is mainly embolic or atherosclerotic, and it often presents with non-specific signs and symptoms (e.g., vertigo, cephalalgia, reduced consciousness, or hemiparesis) that can simulate an anterior circulation stroke. Therefore, obtaining imaging studies that include computed tomography (CT), computed tomography angiography (CTA), and diffusion-weighted magnetic resonance imaging (DWI MRI) as part of the diagnostic approach is crucial to make an accurate diagnosis. The main pillar of acute BAO treatment is early recanalization using intravenous thrombolysis, mechanical thrombectomy, or bridging therapy, in which both methods are used. This pictorial essay illustrates the essential role that multimodal imaging plays in the prompt diagnosis, management, and overall outcome of patients with acute BAO.
© 2021. American Society of Emergency Radiology.

Entities:  

Keywords:  Angiography; Basilar artery ischemia; Mechanical thrombectomy; Posterior circulation infarct; Thrombolytic therapy

Mesh:

Year:  2021        PMID: 34231114     DOI: 10.1007/s10140-021-01965-8

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  1 in total

1.  Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes.

Authors:  Simon D Israeli-korn; Yvonne Schwammenthal; Tali Yonash-Kimchi; Mati Bakon; Rakefet Tsabari; David Orion; Bella Bruk; Noa Molshatzki; Oleg Merzeliak; Joab Chapman; David Tanne
Journal:  Isr Med Assoc J       Date:  2010-11       Impact factor: 0.892

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.